Vegalab US and Fertica Enter Exclusive Distribution Agreement for Guatemala
PALM BEACH, Fla., Jan. 10, 2017 /PRNewswire/ -- HPC Acquisitions, Inc. (OTCQB: HPCQ) DBA Vegalab US, a biotech company focused on delivering biological pesticides and natural fertilizers using its proprietary micronization and nanotechnology, has announced an exclusive distributor agreement with Fertica Group for its products in Guatemala. Fertica is the only manufacturer of edaphic-TVA process fertilizers in Central America and a leading distributor of plant food.
Vegalab US has granted Fertica exclusive rights to promote, market, and sell its line of bioproducts to farmers in Guatemala. Apart from Guatemala, Fertica also operates in El Salvador, Honduras, Nicaragua, Costa Rica and Panama, with total annual sales of $200M.
"We are particularly interested in Vegalab's selection of biopesticides. Biological alternatives to chemical pesticides have attracted much attention here in Guatemala, and we want to provide farmers with the best performing products available," said Julio Martinez, Manager of Fertica for Guatemala.
"We are very excited to have one of Central America's leading distributors of plant protection products partnering with us in our effort to shift the use of chemical pesticides to safer biological pesticides," said Steven Blackburn, Director of Business Development for Vegalab US.
Vegalab US will retain responsibility for product development, quality management, and manufacturing, while Fertica will be responsible for sales, marketing, customer support, and distribution activities in Guatemala.
About Vegalab US
Vegalab US is committed to supporting sustainable agriculture through technological innovation. Our product line consists of biological pesticides, fertilizers, and specialty biological agents that are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. The active ingredients in our solutions consist primarily of oil extracts from various plant sources. Applying our proprietary micronization and nanotechnology to these powerful natural agents allow Vegalab to create products that foster a healthier world.
Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities, and growth prospects, they are based on management's current beliefs and assumptions as to future events. However, since the company's operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated, or implied. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission.
PR contact:
Sarah Andrews
[email protected]
800-208-1680 ext. 715
www.vegalab.us
SOURCE Vegalab
Share this article